Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Edwards EWJ-202 Transcatheter Tricuspid Valve Replacement System: Investigation of Safety and Clinical Efficacy Using a Novel Device in Patients With at Least Severe Tricuspid Regurgitation in JAPAN

NCT05760989 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT05760989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05760989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Edwards EWJ-202 Transcatheter Tricuspid Valve Replacement System: Investigation of Safety and Clinical Efficacy Using a Novel Device in Patients With at Least Severe Tricuspid Regurgitation in JAPAN
Lead sponsor
Edwards Lifesciences
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 6, 2023
Completion date
September 30, 2029
Enrollment
45 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, heart valve diseases, tricuspid valve regurgitation